関連する実験動画

Updated: Sep 9, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

長い非コーディングRNA lnc-FANCI-2は,ヒトパピローマウイルス16型に感染した子宮頸がん細胞におけるRAS信号伝達を本質的に制限する

Haibin Liu¹, Lulu Yu¹, Vladimir Majerciak¹

¹Tumor Virus RNA Biology Section, HIV Dynamics and Replication Program, CCR/NCI/NIH, Frederick, United States.

|August 29, 2025

まとめ

新種の長いノンコーディングRNA lnc-FANCI-2は,RAS信号を調節することで,子宮頸がんの進行を促します. 癌細胞でのノックアウトは細胞の振る舞いを変化させ患者の生存に影響を与え子宮頸部病変の発達におけるその役割を強調しました

科学分野:

腫瘍学
分子生物学
RNA 生物学

背景:

子宮頸がんの進行には複雑な分子変化が伴う
長いノンコーディングRNA (lncRNA) は,がんにおける役割としてますます認識されています.
lnc-FANCI-2は子宮頸部病変に関与する lncRNAを新たに特定したものです.

研究の目的:

子宮頸がんにおけるInc-FANCI-2の機能的役割を調査する.
lnc-FANCI-2が子宮頸部病変の進行に影響を与える分子メカニズムを解明する.
子宮頸がん患者におけるInc- FANCI- 2の予後値の評価

主な方法:

lnc- FANCI-2 ノックアウト (KO) CaSki細胞を生成するために,CRISPR- Cas9 遺伝子編集が使用されました.
細胞形態,増殖,シグナル伝達経路 (RAS,IFN),およびタンパク質発現を分析した.
lnc- FANCI-2のタンパク質相互作用が特定されました.
患者の組織における発現レベルは生存データと相関していた.

主要な成果:

lnc- FANCI- 2 KO細胞は形態と増殖が変化し,RASシグナル伝達 (p- Akt,p- Erk1/ 2) と上皮- 介酵素移行が増加した.
KO細胞はIFN信号への反応が低下した.
lnc- FANCI-2は,MAP4K4を含むタンパク質と相互作用し,MAP4K4のノックダウンがRASシグナル伝達エフェクタに影響を与えます.
高 lnc-FANCI- 2と低 MCAM発現は,患者の生存率の低下と相関しています.

結論:

lnc-FANCI-2は子宮頸がんにおけるRAS信号の重要な調節剤である.
このlncRNAは子宮頸部病変の進行に重要な役割を果たし,患者の予後に影響を与えます.
lnc-FANCI-2をターゲットにすることで子宮頸がんの治療戦略を提案できます

キーワード:

HPV について RASシグナリング RNA生物学がん生物学子宮頸がん人間感染症 lnc-FANCI-2 について微生物学非コーディングRNA

さらに関連する動画

Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR

Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR

Published on: March 1, 2019

In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System

In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System

Published on: January 9, 2020

関連する概念動画

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

The Ras Gene

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...

Non-LTR Retrotransposons

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...

Small GTPases - Ras and Rho

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity: